Lin MH, et al. Real-world brigatinib use in non-small cell lung cancer patients with prior use of crizotinib/other ALK therapies in the US. Abstract P2.16-09. WCLC 2019, 7-10 sept. Barcelona, Spanje.
Leendert Trouw benoemd tot hoogleraar Complementbiologie en -therapie
feb 2023 | Immuuntherapie, RA, Tuberculose